tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Income Statement

Compare
1,497 Followers

Moleculin Biotech Income Statement

Last quarter (Q4 2024), Moleculin Biotech's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Moleculin Biotech's net income was $-1.88M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -127.00K$ -222.00K$ -260.00K$ -285.00K
Operating Expenses
$ 26.64M$ 29.63M$ 30.64M$ 22.97M$ 19.74M
Depreciation and Amortization
$ 126.00K$ 127.00K$ 222.00K$ 260.00K$ 285.00K
EBITDA
$ -26.52M$ -29.50M$ -30.51M$ -22.80M$ -19.54M
Operating Income
$ -26.64M$ -29.63M$ -30.64M$ -22.97M$ -19.74M
Other Income/Expenses
$ 4.88M$ -138.00K$ 1.61M$ 7.07M$ 2.39M
Pretax Income
$ -21.76M$ -29.77M$ -29.02M$ -15.89M$ -17.36M
Net Income
$ -21.76M$ -29.77M$ -27.41M$ -8.86M$ -15.00M
Per Share Metrics
Basic EPS
$ -6.32$ -15.07$ -14.37$ -4.94$ -22.85
Diluted EPS
$ -6.32$ -15.07$ -14.37$ -4.94$ -22.85
Weighted Average Shares Outstanding
3.44M 1.98M 1.91M 1.79M 656.38K
Weighted Average Shares Outstanding (Diluted)
3.44M 1.98M 1.91M 1.79M 656.38K
Currency in USD

Moleculin Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis